Long-Qi Chen
Impact in
- Surgery top 2%
- Esophageal Cancer Research and Treatment
- Esophageal and GI Pathology
- Gastroenterology top 5%
- Gastroesophageal reflux and treatments
Papers in
- Surgery 103
- Esophageal Cancer Research and Treatment 91
- Esophageal and GI Pathology 6
- Minimally Invasive Surgical Techniques 3
-
- Gastroesophageal reflux and treatments 10
- Co-authors
- Yong Yuan (42 shared papers)Yu‐Shang Yang (43 shared papers)Yang Hu (16 shared papers)Wen‐Ping Wang (35 shared papers)Yongfan Zhao (5 shared papers)Weipeng Hu (19 shared papers)Peng-Zhi Ni (10 shared papers)Yong Yuan (1 shared paper)
In The Last Decade
Long-Qi Chen
113 papers receiving 1.6k citations
Long-Qi Chen's Hit Papers
Peers
Comparison fields: 5 of 63
- Surgery 1.2k
- Gastroenterology 114
- Speech and Hearing 68
- Drug Discovery 3
- Oncology 132
Countries citing papers authored by Long-Qi Chen
This map shows the geographic impact of Long-Qi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long-Qi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long-Qi Chen more than expected).
Fields of papers citing papers by Long-Qi Chen
This network shows the impact of papers produced by Long-Qi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long-Qi Chen. The network helps show where Long-Qi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Long-Qi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 120 | |
| 2 | Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial Hit paper breakdown → | 2024 | 118 |
| 3 | 2022 | 84 | |
| 4 | 2009 | 73 | |
| 5 | 2016 | 59 | |
| 6 | 2010 | 55 | |
| 7 | 2016 | 48 | |
| 8 | 2011 | 47 | |
| 9 | 2008 | 45 | |
| 10 | 2011 | 45 | |
| 11 | 2018 | 38 | |
| 12 | 2001 | 35 | |
| 13 | 2022 | 35 | |
| 14 | 2020 | 31 | |
| 15 | 2017 | 30 | |
| 16 | 2022 | 30 | |
| 17 | 2015 | 24 | |
| 18 | 2017 | 24 | |
| 19 | 2021 | 24 | |
| 20 | 2008 | 23 |
About Long-Qi Chen
Long-Qi Chen is a scholar working on Surgery, Gastroenterology, Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 125 papers that have together received 1.7k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (91 papers), Gastroesophageal reflux and treatments (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), Esophageal and GI Pathology (6 papers), Myasthenia Gravis and Thymoma (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Minimally Invasive Surgical Techniques (3 papers). The work is most often cited by research in Surgery (1.2k citations), Gastroenterology (114 citations), Speech and Hearing (68 citations), Drug Discovery (3 citations) and Oncology (132 citations). Long-Qi Chen has collaborated with scholars based in China, Japan and Canada. Frequent co-authors include Yong Yuan, Yu‐Shang Yang, Yang Hu, Wen‐Ping Wang, Yongfan Zhao, Weipeng Hu, Peng-Zhi Ni, Yong Yuan, Han‐Yu Deng and André Duranceau. Their work appears in journals such as Annals of Surgical Oncology, European Journal of Cardio-Thoracic Surgery, The Annals of Thoracic Surgery, International Journal of Surgery and Diseases of the Esophagus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.